Camera to improve radiation targeting for prostate bone tumors
Part of Cancer, Kidney & urinary clinical trials.
This study tests a special camera that may help doctors aim radiation more precisely at bone tumors in people with prostate cancer. It could improve the accuracy of treatment while reducing harm to healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in good general health (able to carry on normal daily activities)
- You have bone metastases from prostate cancer
- You are scheduled to receive stereotactic radiation therapy (high-precision radiation) for your bone tumors
- You have not had radiation therapy to the same bone area before
- You have no other active cancer in the last three years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way of taking pictures of tumors (metastases) using an upgraded gamma camera. The goal is to see if this new method produces clearer images, which could help doctors find and treat cancer better. Participation is only for people who are already having a bone scan or a scan after certain types of radiation therapy.
This trial looks at whether a precise form of radiation (stereotactic body radiotherapy) can control a small number of prostate cancer spots seen on a special scan (PSMA PET/CT). It may help by treating limited metastases while avoiding unnecessary treatment elsewhere.
This study tests a precise type of radiation (stereotactic radiotherapy) for men with early-stage prostate cancer. It aims to see if using custom radiation beams improves outcomes while reducing side effects.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
This trial uses a special imaging scan (SPECT/CT) with a small amount of radioactive tracer to look at prostate cancer. It aims to see how well the scan matches your prostate cancer tests and may help improve detection and assessment.
This trial is testing how well treatments for advanced prostate cancer that has spread to the bones can be seen on scans. It may help doctors find better ways to measure if the cancer is responding to treatment.
Hear when a new Prostatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.